Drugs / Pentavalen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02095314 | Mar → Jun 2014 | — | PT Bio Farma | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-06-13 | PT Bio Farma | Dukung Program Kerjasama Global Pemerintah: Bio Farma Kembali Siapkan 850 ribu Dosis Vaksin Pentavalen untuk Nigeria co.id ↗ |
| 2023-05-30 | PT Bio Farma | Jaga Ketahanan Kesehatan Dunia: Bio Farma Kapalkan 1,5 juta Dosis Vaksin Pentavalen untuk Nigeria co.id ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pentavalen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02095314 ↗ |